(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/06/21 | 日証協 | 249,112株 | -0.92% | 60,000株 | +35.46% | 395,794株 | +0.98% | 163,316株 | +169.07% |
2024/06/14 | 日証協 | 251,418株 | -12.16% | 44,295株 | +7282.5% | 391,944株 | -1.65% | 60,696株 | +6.22% |
2024/06/07 | 日証協 | 286,218株 | -13.56% | 600株 | -48.5% | 398,537株 | -6.35% | 57,144株 | +2.91% |
2024/05/31 | 日証協 | 331,118株 | -1.08% | 1,165株 | -92.85% | 425,542株 | -3.43% | 55,527株 | -55.69% |
2024/05/24 | 日証協 | 334,720株 | -5.69% | 16,293株 | -93.18% | 440,639株 | -2.35% | 125,306株 | +76.11% |
2024/05/17 | 日証協 | 354,912株 | +10.96% | 238,743株 | +28.26% | 451,242株 | +4.62% | 71,151株 | -19.02% |
2024/05/10 | 日証協 | 319,851株 | -7.6% | 186,135株 | +749.93% | 431,334株 | -2.18% | 87,864株 | -30.05% |
2024/05/02 | 日証協 | 346,151株 | -1.2% | 21,900株 | -87.68% | 440,952株 | +1.47% | 125,613株 | +79.78% |
2024/04/26 | 日証協 | 350,351株 | -4.66% | 177,702株 | -45.74% | 434,558株 | -0.98% | 69,870株 | -65.44% |
2024/04/19 | 日証協 | 367,484株 | +17.07% | 327,482株 | +19.83% | 438,840株 | -2.29% | 202,146株 | +113.15% |
2024/04/12 | 日証協 | 313,912株 | -3.4% | 273,298株 | +215.75% | 449,118株 | +2.55% | 94,838株 | -30.15% |
2024/04/05 | 日証協 | 324,951株 | -6.42% | 86,556株 | -31.28% | 437,961株 | +0.57% | 135,772株 | +60.83% |
2024/03/29 | 日証協 | 347,259株 | +1.22% | 125,951株 | -56.7% | 435,473株 | +4.11% | 84,419株 | +74% |
2024/03/22 | 日証協 | 343,059株 | +5.81% | 290,904株 | +121.38% | 418,284株 | +2.52% | 48,516株 | +7.27% |
2024/03/15 | 日証協 | 324,209株 | -7.56% | 131,402株 | +88% | 408,021株 | -1.82% | 45,228株 | +30.34% |
2024/03/08 | 日証協 | 350,709株 | +9% | 69,893株 | -75.85% | 415,594株 | -7.28% | 34,701株 | -72.79% |
2024/03/01 | 日証協 | 321,746株 | -0.56% | 289,453株 | +5277.17% | 448,234株 | -0.88% | 127,511株 | +170.67% |
2024/02/22 | 日証協 | 323,546株 | -6.99% | 5,383株 | -96.55% | 452,213株 | -0.54% | 47,110株 | -49.83% |
2024/02/16 | 日証協 | 347,879株 | -28.03% | 156,041株 | -67.91% | 454,684株 | -10.61% | 93,900株 | -36.05% |
※株式分割は考慮していませんのでご注意ください。
Page Top